XBiotech Inc

Healthcare · Biotechnology

2.20$ -0.9% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

XBiotech Inc (XBIT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 134 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet XBIT
Line item	Q4 16	Q1 17	Q2 17	Q3 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	67	88	78	71	71	63	59	54	49	44	40	72	67	817	358	359	353	354	356	354	280	275	271	266	251	246	242	235	230	227	228	216	210	199	182	179	172	150	140	134
Current Assets	37	57	47	40	40	33	30	26	21	17	13	46	41	716	258	258	252	326	328	325	250	247	243	239	223	220	216	210	204	202	203	191	185	175	158	155	149	127	117	111
Cash	34	55	46	39	39	32	28	25	21	16	12	45	40	715	242	230	238	237	240	315	239	237	232	226	161	157	152	143	202	200	201	189	183	173	156	153	147	126	115	110
Cash & Short-Term Investments	34	55	46	39	32	32	28	25	21	16	12	45	40	715	242	230	238	237	240	315	239	237	232	226	220	217	213	205	202	200	201	189	183	173	156	153	147	126	115	110
Receivables	–	–	–	–	–	–	–	–	–	–	–	–	–	–	13	26	12	4.1	1.7	8.1	10	9.0	11	12	2.7	1.8	2.9	3.8	1.3	0.9	0.9	1.0	0.9	0.9	0.6	0.6	0.5	0.4	0.3	0.3
Inventory	0.0	0.0	0.0	–	0.0	0.0	0.0	0.0	0.0	–	–	–	–	–	–	–	0.0	0.0	–	–	0.0	-9.0	0.0	–	-62	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Property, Plant & Equipment	10	31	31	30	30	30	29	29	28	27	27	26	26	25	25	25	26	27	28	28	29	28	28	27	27	26	26	26	–	–	–	–	–	–	–	–	–	–	–	–
Goodwill	0.0	0.0	0.0	–	0.0	0.0	0.0	0.0	0.0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Intangible Assets	0.0	0.0	0.0	–	0.0	0.0	0.0	0.0	0.0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Total Liabilities	8.0	5.3	4.7	3.5	3.5	2.8	2.5	2.8	2.3	2.9	2.8	2.5	2.0	61	11	15	7.3	5.1	3.8	5.4	5.4	5.8	5.2	11	6.0	5.7	5.2	6.1	6.9	7.8	19	19	18	17	7.2	5.6	5.3	9.7	4.8	5.2
Current Liabilities	8.0	5.3	4.7	3.5	3.5	2.8	2.4	2.8	2.3	2.9	2.8	2.5	2.0	60	10	14	6.2	4.0	2.7	3.9	3.9	3.5	2.9	8.2	3.6	4.1	3.6	4.5	5.3	6.1	17	17	16	15	5.4	3.9	3.6	7.9	3.0	3.4
Short-Term Debt	–	–	–	–	–	–	–	–	–	–	–	–	–	49	1.7	2.6	–	–	–	–	–	–	–	–	–	–	–	–	–	–	10	10	10	10	10	–	–	–	–	–
Accounts Payable	4.4	2.7	3.4	2.2	2.8	1.7	1.2	1.5	0.9	1.7	1.9	1.6	1.1	2.1	5.6	5.2	3.9	2.5	1.2	1.5	1.0	2.1	1.3	2.5	1.4	2.4	1.4	1.8	1.5	2.5	2.6	1.7	1.5	2.2	1.1	1.4	1.0	1.5	0.9	1.1
Long-Term Debt	0.0	0.0	0.0	–	0.0	0.0	0.0	0.0	0.0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Shareholders' Equity	59	82	73	67	60	60	56	52	47	41	37	69	65	756	347	344	346	349	352	349	274	269	266	256	245	240	237	229	223	219	209	197	192	182	175	173	167	140	135	128
Retained Earnings	-183	-194	-203	-209	-209	-217	-221	-227	-232	-238	-244	-249	-256	431	104	97	95	98	95	90	12	5.2	-0.2	-12	-25	-28	-32	-40	-48	-52	-62	-75	-80	-91	-102	-103	-109	-136	-142	-149
Shares Outstanding	33	33	35	35	–	35	35	36	36	36	36	38	41	36	36	29	29	29	29	30	30	30	30	30	30	30	30	30	30	30	30	30	30	30	30	30	30	30	30	30

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings